Could a common diabetes drug help preemies breathe easier?
NCT ID NCT07120971
First seen Jan 26, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study is testing whether metformin, a medicine used for diabetes, is safe and tolerable for premature infants who have or are at risk for bronchopulmonary dysplasia (BPD), a chronic lung condition. The trial has two phases: one for older premature infants already diagnosed with BPD, and one for younger, high-risk infants. The main goal is to see how well these babies tolerate the drug and to check for side effects like low blood sugar or feeding problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.